Navco Pharmaceuticals Inc (NAV.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Operating Expenses | 8 | 14 | 11 | 23 | 2 |
| Operating Income | -8 | -14 | -11 | -23 | -2 |
| Other Income | 1 | 0 | 0 | 0 | 1 |
| Pre-tax Income | -7 | -14 | -11 | -23 | -2 |
| Net Income Continuous | -7 | -14 | -11 | -23 | -2 |
| Net Income | $-7 | $-14 | $-11 | $-23 | $-2 |
| EPS Basic Total Ops | 0.00 | -0.01 | 0.00 | -0.01 | 0.00 |
| EPS Basic Continuous Ops | 0.00 | -0.01 | 0.00 | -0.01 | 0.00 |
| EPS Diluted Total Ops | 0.00 | -0.01 | 0.00 | -0.01 | 0.00 |
| EPS Diluted Continuous Ops | 0.00 | -0.01 | 0.00 | -0.01 | 0.00 |
| EBITDA(a) | $-8 | $-14 | $-11 | $-23 | $-2 |